Holmes L - Search Results

1

Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.

McLaughlin P, Fuller L, Redman J, Hagemeister F, Durr E, Allen P, Holmes L, Velasquez W, Swan F, Cabanillas F. McLaughlin P, et al. Among authors: holmes l. Ann Oncol. 1991 Feb;2 Suppl 2:137-40. doi: 10.1007/978-1-4899-7305-4_21. Ann Oncol. 1991. PMID: 1710918 Free article. Clinical Trial.

2

Long-term results of treatment of patients with follicular lymphomas.

Kalter S, Holmes L, Cabanillas F. Kalter S, et al. Among authors: holmes l. Hematol Oncol. 1987 Apr-Jun;5(2):127-38. doi: 10.1002/hon.2900050207. Hematol Oncol. 1987. PMID: 2439430

3

Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer.

Shuford S, Wilhelm C, Rayner M, Elrod A, Millard M, Mattingly C, Lotstein A, Smith AM, Guo QJ, O'Donnell L, Elder J, Puls L, Weroha SJ, Hou X, Zanfagnin V, Nick A, Stany MP, Maxwell GL, Conrads T, Sood AK, Orr D, Holmes LM, Gevaert M, Crosswell HE, DesRochers TM. Shuford S, et al. Among authors: holmes lm. Sci Rep. 2019 Aug 1;9(1):11153. doi: 10.1038/s41598-019-47578-7. Sci Rep. 2019. PMID: 31371750 Free PMC article.

4

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study.

Wei YC, Sticca RP, Li J, Holmes LM, Burgin KE, Jakubchak S, Bouton-Verville H, Williamson J, Meyer K, Evans L, Martin J, Stephenson JJ, Trocha S, Smith S, Wagner TE. Wei YC, et al. Among authors: holmes lm. Oncol Rep. 2007 Sep;18(3):665-71. Oncol Rep. 2007. PMID: 17671717

5

Glycoinositol phospholipid-anchored interleukin 2 but not secreted interleukin 2 inhibits melanoma tumor growth in mice.

Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y. Ji J, et al. Mol Cancer Ther. 2002 Oct;1(12):1019-24. Mol Cancer Ther. 2002. PMID: 12481424

6

Targeting foreign major histocompatibility complex molecules to tumors by tumor cell specific single chain antibody (scFv).

Li J, Franek KJ, Patterson AL, Holmes LM, Burgin KE, Ji J, Yu X, Wagner TE, Wei Y. Li J, et al. Among authors: holmes lm. Int J Oncol. 2003 Nov;23(5):1329-32. Int J Oncol. 2003. PMID: 14532973

7

Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.

Li J, Ji J, Holmes LM, Burgin KE, Barton LB, Yu X, Wagner TE, Wei Y. Li J, et al. Cancer Gene Ther. 2004 May;11(5):363-70. doi: 10.1038/sj.cgt.7700707. Cancer Gene Ther. 2004. PMID: 15044960

8

Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12.

Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y. Ji J, et al. J Gene Med. 2004 Jul;6(7):777-85. doi: 10.1002/jgm.547. J Gene Med. 2004. PMID: 15241785

9

Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent.

Li J, Bouton-Verville H, Holmes LM, Burgin KE, Jakubchak S, Yu X, Wagner TE, Wei Y. Li J, et al. Anticancer Res. 2004 Sep-Oct;24(5A):2717-21. Anticancer Res. 2004. PMID: 15517877 Free article.

10

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.

Wei Y, Sticca RP, Holmes LM, Burgin KE, Li J, Williamson J, Evans L, Smith SJ, Stephenson JJ, Wagner TE. Wei Y, et al. Among authors: holmes lm. Int J Oncol. 2006 Mar;28(3):585-93. Int J Oncol. 2006. PMID: 16465362 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

846 results

Search Page

Filters